By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
RESI Boston September is now just 4 days away!
In this conference cycle, we will be showcasing over 50 Innovator’s Pitch Challenge (IPC) Finalists across therapeutics, medical devices, diagnostics, digital health, R&D / life science tools, and more. These companies will be pitching in a live session with a panel of investor and industry expert judges and engage in Q&A. We are thankful for all of the judges who will be participating and providing valuable feedback and questions to the IPC finalist companies. The judges collectively represent over 40 unique firms, including some of the most active investors in the life science industry.
Whether you are an actively fundraising early-stage company, or an active investor/strategic partner looking for targeted dealflow, it is still not too late to register and engage with over 700 attendees in-person or virtually, as well as listen in on our robust program of panels, pitch sessions, and workshops throughout the whole day on Monday, September 18, at the Boston Park Plaza.
Below are the participating judges. See you all next week!
 Yoola Adeniji Associate LRVHealth |
 Christopher Aleong Managing Director, North America BioEngine Capital |
 Paula Andrea Lengerke Diaz Advisor Desert Angels |
 Jenna Aronson Principal Two Bear Capital |
 Jay Batchu Entrepreneur in Residence Xontogeny |
 Rick Berenson Director – Executive Board Mass Medical Angels |
 Tara Bishop Founder Black Opal Ventures |
 Eric Boutin Venture Chair Redesign Health |
 Gennady Bratslavsky Co-Founder Avicella Ventures |
 James Carroll Managing Director for Life Science Investments Wharton Alumni Angels |
 Asmi Chakraborty Fellow Breakout Ventures |
 Benjamin Chen Venture Partner Panacea Ventures |
 Bruce Cohen Venture Partner Xeraya Capital |
 Lise Courtney D’Amico Senior Associate LRVHealth |
 Travis D’Cruz Associate Director, Early Innovation Partnering Johnson & Johnson Innovation |
 Ronald Dorenbos Principal BioFrontline Ltd. |
 David Fogel Member of Screening & Due Diligence Committees Mass Medical Angels |
 Gabriella Garcia Investor Two Sigma Ventures |
 Martin Gershon Managing Partner Endeavor Venture Fund & Venture Studio |
 Joe Graham Vice President Danaher Corporation |
 Jasmine Gruia-Gray CEO JGG Consulting |
 Michael Hansen Innovation Scouting Director – North America Eppendorf |
 Z Haroon Chairman and General Partner Julz Co LLC |
 Travis Hughes Research Analyst Digitalis Ventures |
 Daniyal Hussain Executive Director, Technology Business Development GlaxoSmithKline (GSK) |
 Kristin King Member Boston Harbor Angels |
 Merom Klein Entrepreneur Mentor Keiretsu Forum |
 Adam Kundzewicz Executive Director Boehringer Ingelheim Venture Fund |
 Nicola La Monica Sr. Director, Infectious Diseases and Vaccines Scientific Innovation, Janssen Johnson & Johnson Innovation |
 Seo Lee Director SV Investment |
 Mark Legare Senior Associate Innospark Ventures |
 Alan Lucas Founder NE Healthcare Executive Network |
 Greg McKee Managing Partner Bonaventure Equity, LLC (BVE) |
 Peter Mintun Associate ARCH Venture Partners |
 Paul Papi Corporate Communications DiaMedica Therapeutics |
 John Pennett Angel Investor Mid Atlantic Bio Angels |
 Jack Resnick Inception Program Specialist NVIDIA VC Alliance |
 Colin Sheehan Associate Director, Ventures Orange Grove Bio |
 Prithviraj Singha Roy Senior Associate RA Capital |
 Mariola Szenk Senior Associate BlueYard Capital |
 Wei Tao Board Director & Chair, Bio/Genomics Life Science Angels |
 Justin Williams Senior Associate Seae Ventures |
 Rosanna Zhang Partner Coho Deeptech |
 Yuan Zhang Senior Director, Scientific Operations & Strategy Portal Innovations |
 Tingting Zhang-Kharas Head, Johnson & Johnson Innovation – JLABS US Northeast Johnson & Johnson Innovation |
Next Phase Newsletter 
Leave a comment